Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review
Considering that osteoarthritis (OA) is the most prevalent joint disease worldwide, multiple pharmacological treatments have been proposed to alter the articular structure with potential benefit in the progression of the disease. The so-called disease-modifying OA drugs have been frequently investigated but conclusive findings are rare. Strontium ranelate (SrRan) is a drug usually prescribed to treat osteoporosis, with proven effects in decreasing the risk of fractures and possible effect in reducing the progression of OA. The objective of this review was to demonstrate the current panorama of knowledge on the use of SrRan in clinical and experimental models, clarifying its mechanisms of action and describing possible anti-nociceptive and anti-inflammatory effects. The systematic review was based on the PRISMA statement and included articles that are indexed in scientific databases. Fifteen studies were included: seven pre-clinical and eight clinical studies. Despite the limited number of studies, the results suggest a positive effect of SrRan in patients with OA, through changes in functional capacity and reduction of progression of morphological parameters and joint degradation, with moderate quality of evidence for those clinical outcomes. Novel studies are necessary to elucidate the molecular targets of SrRan, focusing on anti-inflammatory effects and histological changes promoted by SrRan, which seemed to reduce the progression of OA in the experimental and clinical studies.
Autores principales: | Rodrigues,T.A., Freire,A.O., Bonfim,B.F., Cartágenes,M.S.S., Garcia,J.B.S. |
---|---|
Formato: | Digital revista |
Idioma: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2018
|
Acceso en línea: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2018000800302 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of strontium ranelate on pain behavior in an experimental model of osteoarthritis
por: Rodrigues,T.A., et al.
Publicado: (2017) -
Effects of Strontium Ranelate on Alveolar Ridge Morphology Augmentation
por: Xuan,Jing, et al.
Publicado: (2017) -
Strontium ranelate inhibits wear particle-induced aseptic loosening in mice
por: Geng,Tianxiang, et al.
Publicado: (2018) -
Strontium Ranelate Effect on the Repair of Bone Defects and Molecular Components of the Cortical Bone of Rats
por: Rosa,Jucely Aparecida da, et al.
Publicado: (2016) -
Absence of medication-related jaw osteonecrosis after treatment with strontium ranelate in ovariectomized rats
por: MECCA,Leomar Emanuel de Almeida, et al.
Publicado: (2022)